CEA, a cell-surface glycoprotein that is expressed in normal mucosal cells and overexpressed in a wide variety of adenocarcinomas, including colon, rectum, breast, pancreas, and lung, has been recognized as one of the most useful tumor markers in clinical practice [2]. The gene discussed is CEACAM5; the disease is neoplasm.